The role of nelarabine in the treatment of T-cell acute lymphoblastic leukemia: literature review and own experience

Aim. The analysis of experience of nelarabine use in refractory/relapsed T-cell acute lymphoblastic leukemia (T-ALL) depending on the immunophenotype and the line of therapy. Materials and methods. All the patients with relapsed or refractory T-ALL aged from 0 to 18 years who received treatment with...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Y Y DYAKONOVA, O I BYDANOV, A M POPOV, Y V OLSHANSKAYA, E G BOICHENKO, O V ALEYNIKOVA, M A MASCHAN, L N SHELIKHOVA, D V LITVINOV, L A KHACHATRYAN, N I PONOMAREVA, L G FECHINA, G A NOVICHKOVA, E D PASHANOV, A I KARACHUNSKIY
Format: Artigo
Idioma:Russo
Publicat: "Consilium Medicum" Publishing house 2018-07-01
Col·lecció:Терапевтический архив
Matèries:
nelarabine
9-β-d-arabinofuranosylguanine (ara-g)
relapsed/refractory t cell acute lymphoblastic leukemia
acute lymphoblastic leukemia
t-all immunophenotyping
moscow-berlin protocol
Accés en línia:https://ter-arkhiv.ru/0040-3660/article/viewFile/32769/pdf
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars